ENCORE CAPITAL GROUP, INC. (ECPG): what the price assumes

boothcheck covers ENCORE CAPITAL GROUP, INC. (ECPG) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/ECPG

Headline

FieldValue
TickerECPG
CompanyENCORE CAPITAL GROUP, INC.
Sector / IndustryFinancial Services
Current price$97.30/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)62.8%
Operating margin today36.8%
Margin expansion (value-band)+26.0pp
Multiple paid3x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 10.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: n/a

ReferenceValue
vs own history-0.72σ

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.65x5justifies
Earnings0.53x3justifies
Relative0.43x4justifies
Growth0.46x2justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.1%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
DCF Exit MultipleGrowth$316.660.31xyesExit EV/EBITDA: 5.3x / 8.3x / 11.3x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelative$198.960.49xyesP/E 12x (static sector reference · 2026-04), scenarios: 9.6x / 12.0x / 14.4x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$149.390.65xyesBV/sh $48.26, ROE (TTM) 28.6%, ke 9.3%
Two-Stage Excess ReturnAsset$269.070.36xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$159.710.61xyesRev $1.9B, growth 30% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.1x / 1.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$154.080.63xyesEPS $12.84, growth 1% (input: historical EPS growth), PEG=5.96 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$185.040.53xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.39B × (1−23%) / WACC 4.1% → EPV (no growth)
Residual IncomeAsset$226.130.43xyesBV $48.26 + 5yr PV of (ROE (TTM) 28.6% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$118.080.82xyes√(22.5 × EPS $12.84 × BVPS $48.26) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$0.019730.00xyesFCF $166.1M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF YieldEarnings$0.019730.00xyesSBC-adj FCF $0.15B (FCF $0.17B − SBC $0.02B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings$414.300.23xyesEPS $12.84 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$34.752.80xyesBV $48.26 × (ROIC 2.9% / WACC 4.1%)
P/Sales SectorRelative$259.060.38xyesRevenue $1.85B × sector P/S 3.0x
PEG Fair ValueRelative$481.500.20xyesEPS $12.84 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$138.810.70xyesEPS $12.84 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Debt purchasing and recoveryoperatingenterprise1.8B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$3.8b
Net debt / NOPAT (after-tax)7.24x
Net debt / operating income (pre-tax)5.59x
Interest coverage2.3x
Share count CAGR (buyback)-5.1%
Burning cashno

Bullet Takeaways

Bull Case

Most companies own things you can photograph. Encore owns forecasts. It buys pools of consumer accounts that banks and card issuers have already given up on, pays a small fraction of the face amount, and then spends years recovering what it can. The accounting follows the same logic: Revenue is recognized for each static pool over the economic life of the pool. Which means the income statement is a schedule of expectations, and the only honest audit of it is whether the cash actually shows up.

Lately it has. Collections from purchased receivables came to $718.4 million in the three months to March 2026, against $604.8 million in the same quarter a year earlier. Over the same comparison, receivable portfolio purchases net of put-backs were $359.5 million and $362.7 million, so the company spent about the same money and got roughly a fifth more cash back. In a business where returns are locked in at the moment of purchase and only revealed years later, an improving ratio of collections to deployment is the closest thing to a live scorecard.

The buying environment explains part of why. The March 2026 10-Q reports that Portfolio purchases in the U.S. were robust as supply increased and pricing remained at favorable levels. Issuers have also been selling newer paper, which the annual filing describes as fresh portfolios sold generally within six months of the account being charged off. Fresh accounts have better contact information, more recent balances, and consumers who have not yet been through five other collection agencies. Paying a favorable price for better paper is the whole game, and both halves of that were available in the United States.

The returns show up where they should. On a trailing basis the company earns about 28.6% on its equity, against a stated book value of $46.36 a share and a price of $89.74. Management restarted buying back stock in 2025 after two years of doing nothing of the sort, repurchasing 2,117,733 shares for $89.5 million, and the board added a further $300.0 million of authorization. A company that stops repurchasing when capital is better deployed into portfolios and restarts when it is not is at least allocating with a view rather than on a schedule.

Put together, the bull case does not need the business to change. It needs the collection estimates already on the balance sheet to prove out roughly as booked, and the March quarter's cash gives that a fair hearing.

Bear Case

Read the raw material honestly and the cycle problem becomes obvious. The FY2025 10-K explains that With lending and charge-off rates remaining near recent peak levels, U.S. portfolio supply continues to be robust. Strip the phrasing away and the sentence says the input is plentiful because American households are failing at close to the highest rate of the cycle. That is not a criticism of the company; it is a description of what drives its volumes. The other half of the cycle is visible in the same filing, in Europe, where default rates are described as generally low by historic levels, consumer lending volumes have stagnated, and portfolio pricing remains competitive across our European footprint, constraining how much capital can be put to work at acceptable returns. One company, two ends of the same cycle, and the profitable end requires the distress to continue.

The second issue is what the balance sheet actually contains. The carrying value of the receivable portfolios, 4.37 billion dollars entering 2026, is an estimate of cash to be collected over the following decade, and the annual report's collection schedule runs out into the 2030s. Revenue is the accretion of that estimate. When the estimate turns out to be optimistic, the correction arrives as a change in recoveries rather than as a missed sale, which is a quieter way for bad news to travel. A ten-year forecast marked by the people who made it is a legitimate thing to discount, and the market is discounting it.

Then there is the legal machinery underneath the cash. The 10-K states that We generate a significant portion of our revenue by collecting on judgments that are granted by courts in lawsuits filed against consumers. That revenue therefore depends on courts continuing to grant such judgments, on statutes of limitation staying where they are, and on state collection rules not tightening. The filing also notes penalties running to 1 million dollars a day for knowing violations of the relevant consumer statutes. Regulatory change in this industry does not shave a margin; it changes what is collectable across the entire book at once.

The financing structure sharpens all of it. The portfolios are funded with borrowings, and operating profit covers the interest bill only about 2.2 times over. For a business whose principal asset is a forecast, that is thin. A modest downward revision to expected collections would pass through the borrowing stack before it reached the equity, and the equity is the piece with the least protection. Currency adds noise on top: the pound moved roughly 6.6% against the dollar between the March 2025 and March 2026 quarters, which is enough to change the reported shape of the European business without anything happening operationally.

Finally, the returns are set on the day the paper is bought, and the company competes for it. We face bidding competition in our acquisition of charged-off consumer receivables. When capital floods into buying charged-off debt, prices rise and forward returns fall, and nobody finds out for several years. The European commentary is that process happening in real time. None of this makes the shares expensive on the standard frames. It explains why the standard frames are not what the market is pricing.

Valuation

The unusual feature here is not how far the price reaches. It is that it does not reach at all. Every family of method used to triangulate this business lands above today's $89.74, and the price sits below what even a 5% a year decline in operating profit would warrant. That is a boundary rather than a solved figure, and it is the kind of reading that normally signals either a mispricing or a risk the models do not encode.

The plain arithmetic is straightforward enough. Stated book value works out to 46.36 dollars of equity behind each share, against a price of $89.74, and the business earned about 28.6% on that equity on a trailing basis, while trailing earnings per share were $12.84. Under two times book, for a return on equity most lenders would be delighted with. The asset-value methods, which start from book and add the value of returns earned above the cost of equity, sit well above the price on that basis, and so do the peer-multiple and cash-flow frames.

What the models do not encode is the nature of the asset. Encore's book is a schedule of expected collections stretching into the 2030s, and its income statement is the accretion of that schedule. The check on whether that schedule is honest is what gets banked, and in the March 2026 quarter it cooperated: collections from purchased receivables of $718.4 million against $604.8 million a year earlier, achieved on portfolio buying that was essentially flat year over year. More coming out of the book, roughly the same going in. That relationship is the single most useful figure in the report, because it is the one thing management cannot restate.

Leverage is the reason the discount persists rather than closing. The receivable portfolios stood at 4.37 billion dollars entering 2026, funded largely with borrowings, and operating profit covers the interest bill about 2.2 times over. Coverage at that level is workable while collections run to forecast and uncomfortable if they do not, which is the same sentence as saying the equity carries the estimate risk. The company has begun returning capital again, repurchasing 2,117,733 shares for $89.5 million in 2025 with a further $300.0 million authorized, so the discount is at least being harvested rather than merely observed.

Catalysts

Second-quarter results are scheduled for August 5, 2026, following the first-quarter release on May 6, 2026. The two lines worth reading first are collections against the $718.4 million banked in the March quarter and the pace of deployment, since together they say whether the improving cash-to-purchases relationship held for a second quarter.

The capital structure has been substantially reworked this year. In May 2026 the company priced an upsized senior secured notes offering and an upsized senior secured floating rate notes offering within days of each other, and on July 22, 2026 it announced the redemption of all outstanding 4.00% convertible senior notes due 2029. Retiring the convertible removes a claim that would have converted into shares at the worst possible moment, namely a strong one, and replaces it with debt that dilutes nobody. It also swaps a low coupon for market-rate secured funding, so the interest bill is the thing to watch on the next print.

The geographic split is the third thing in motion. The March 2026 10-Q describes robust United States purchasing with supply up and pricing favorable, while capital deployment in Europe fell over the same period, with the annual filing attributing that to competitive portfolio pricing across the European footprint. If US supply stays near peak charge-off levels and European pricing stays tight, the mix of where new capital goes will keep shifting toward the market where returns are currently available.

Peer Cohorts (Per Segment, With Filing Citations)

Debt purchasing and recovery (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

company announcement, July 6, 2026 · company announcements, May 11 and May 13, 2026 · company announcement, July 22, 2026

View the full interactive ECPG report on boothcheck